Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

AUP1 Inhibitors

AUP1 inhibitors constitutes a distinct group of organic compounds that modulate the enzymatic activity of AUP1 (ancient ubiquitous protein 1). AUP1 plays a pivotal role in cellular lipid droplet biology, acting as a key regulator in both the formation and degradation of lipid droplets, which are crucial organelles involved in lipid storage and cellular energy homeostasis. Inhibitors within this class are thoughtfully engineered to interact with specific binding sites on the AUP1 protein, thereby influencing its functional roles in cellular lipid metabolism. The development and exploration of AUP1 inhibitors require a comprehensive approach, encompassing molecular modeling, structural analyses, and in-depth investigations into the molecular interactions between these inhibitors and the AUP1 enzyme. This multifaceted strategy aims to optimize the inhibitors for increased specificity towards AUP1, heightened potency, and improved compatibility within the cellular environment. A profound understanding of the structural intricacies of AUP1 and its role in lipid droplet dynamics is essential for the rational design of effective inhibitors within this chemical class.

The primary objective driving the investigation and design of AUP1 inhibitors is to unravel the molecular intricacies governing lipid droplet regulation mediated by AUP1. These inhibitors serve as essential tools for dissecting the mechanisms through which AUP1 influences lipid storage, turnover, and related cellular processes. By selectively inhibiting AUP1, researchers aim to uncover the precise molecular mechanisms that underlie lipid droplet dynamics. The ongoing refinement and exploration of AUP1 inhibitors are essential for advancing our understanding of cellular lipid metabolism and the fundamental processes that govern lipid droplet biology. Through the elucidation of AUP1 inhibition, scientists gain a deeper appreciation for the intricate molecular mechanisms driving lipid droplet formation and degradation within cells, revealing new insights into the broader cellular significance of AUP1 and its influence on lipid-related cellular functions.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

N-Ethylmaleimide

128-53-0sc-202719A
sc-202719
sc-202719B
sc-202719C
sc-202719D
1 g
5 g
25 g
100 g
250 g
$22.00
$69.00
$214.00
$796.00
$1918.00
19
(1)

A widely-used compound that can modify cysteine residues, NEM has been reported to inhibit AUP1 activity in the context of ER-associated protein degradation.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

A compound primarily used as an antineoplastic agent, hydroxyurea has been reported to inhibit AUP1.

Atglistatin

1469924-27-3sc-503147
5 mg
$330.00
(0)

Initially identified as a selective inhibitor of adipose triglyceride lipase (ATGL), atglistatin has been suggested to indirectly influence AUP1 due to its involvement in lipid metabolism pathways.

Gallotannin

1401-55-4sc-202619
sc-202619A
sc-202619B
sc-202619C
sc-202619D
sc-202619E
sc-202619F
1 g
10 g
100 g
250 g
1 kg
2.5 kg
5 kg
$26.00
$37.00
$67.00
$78.00
$234.00
$536.00
$983.00
12
(1)

A naturally occurring polyphenol with diverse biological activities, tannic acid has been studied for its potential to inhibit ER-associated degradation, which may involve AUP1.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

Although known as an inhibitor of autophagy, 3-MA might also impact lipid metabolism pathways, potentially affecting AUP1-regulated processes.

Salicylic acid

69-72-7sc-203374
sc-203374A
sc-203374B
100 g
500 g
1 kg
$47.00
$94.00
$119.00
3
(1)

A compound with anti-inflammatory properties, salicylic acid has been suggested to have effects on ER-associated degradation, which could potentially involve AUP1.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

A compound known to disrupt ER calcium homeostasis, thapsigargin has been reported to impact ER-associated degradation, potentially affecting AUP1.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A widely-used proteasome inhibitor, MG-132 can indirectly influence AUP1 activity by modulating ER-associated degradation pathways.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

A compound that disrupts protein glycosylation in the ER, tunicamycin has been suggested to impact ER-associated degradation, potentially involving AUP1.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

A compound known to activate adenylate cyclase, forskolin has been studied for its impact on lipid metabolism pathways, which may indirectly affect AUP1.